Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) Return on Sales (2016 - 2026)

Insmed's Return on Sales history spans 14 years, with the latest figure at 0.01% for Q1 2026.

  • Quarterly Return on Sales rose 2.0% to 0.01% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.01% through Mar 2026, up 1.0% year-over-year, with the annual reading at 0.02% for FY2025, 0.0% changed from the prior year.
  • Return on Sales came in at 0.01% for Q1 2026, up from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2026 to a low of 0.03% in Q2 2024.
  • The 5-year median for Return on Sales is 0.02% (2024), against an average of 0.02%.
  • Year-over-year, Return on Sales decreased -2bps in 2023 and then rose 2bps in 2026.
  • Insmed's Return on Sales stood at 0.03% in 2022, then rose by 18bps to 0.02% in 2023, then fell by -1bps to 0.02% in 2024, then surged by 45bps to 0.01% in 2025, then soared by 57bps to 0.01% in 2026.
  • Per Business Quant, the three most recent readings for INSM's Return on Sales are 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.03% (Q3 2025).